Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like <b>Genetic Technologies</b> Announces Comprehensive Review Of Strategic Alternatives August 27, 2017 Nestle Emerges as the Frontrunner for Merck KGaA's $5B Consumer Health Biz January 9, 2018 Novartis AG Lures Superstar Scientist Away From UCSF August 16, 2017